TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Asker Healthcare Group AB ( (SE:ASKER) ) has provided an announcement.
Asker Healthcare Group AB reported a strong third quarter in 2025, with a 25% increase in adjusted EBITA, driven by both organic growth and strategic acquisitions. The company has expanded its footprint in the European healthcare market, including a significant entry into the French market through the acquisition of Finmed Group, enhancing its product offerings and market position.
The most recent analyst rating on (SE:ASKER) stock is a Hold with a SEK90.00 price target. To see the full list of analyst forecasts on Asker Healthcare Group AB stock, see the SE:ASKER Stock Forecast page.
More about Asker Healthcare Group AB
Asker Healthcare Group AB operates in the healthcare industry, focusing on providing medical devices, equipment, and related services to hospitals and healthcare institutions. The company is actively expanding its market presence through strategic acquisitions, particularly in Europe.
Average Trading Volume: 1,148,729
Technical Sentiment Signal: Strong Sell
Current Market Cap: SEK34.14B
For a thorough assessment of ASKER stock, go to TipRanks’ Stock Analysis page.